- Home
- BAP vs FMS Comparison
BAP vs FMS Comparison
Compare BAP & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAP
- FMS
- Stock Information
- Founded
- BAP 1889
- FMS 1996
- Country
- BAP Peru
- FMS Germany
- Employees
- BAP N/A
- FMS N/A
- Industry
- BAP Major Banks
- FMS Misc Health and Biotechnology Services
- Sector
- BAP Finance
- FMS Health Care
- Exchange
- BAP Nasdaq
- FMS Nasdaq
- Market Cap
- BAP 17.7B
- FMS 15.9B
- IPO Year
- BAP 1995
- FMS 1996
- Fundamental
- Price
- BAP $235.81
- FMS $26.43
- Analyst Decision
- BAP Buy
- FMS Hold
- Analyst Count
- BAP 4
- FMS 1
- Target Price
- BAP $227.25
- FMS $30.00
- AVG Volume (30 Days)
- BAP 325.4K
- FMS 220.1K
- Earning Date
- BAP 08-07-2025
- FMS 08-05-2025
- Dividend Yield
- BAP 4.67%
- FMS 2.16%
- EPS Growth
- BAP 15.58
- FMS 27.83
- EPS
- BAP 19.76
- FMS 2.28
- Revenue
- BAP $5,114,481,827.00
- FMS $21,068,786,202.00
- Revenue This Year
- BAP $25.40
- FMS $2.74
- Revenue Next Year
- BAP $6.06
- FMS $3.60
- P/E Ratio
- BAP $11.93
- FMS $23.20
- Revenue Growth
- BAP 14.82
- FMS 0.10
- 52 Week Low
- BAP $153.27
- FMS $17.93
- 52 Week High
- BAP $240.00
- FMS $30.46
- Technical
- Relative Strength Index (RSI)
- BAP 72.82
- FMS 39.71
- Support Level
- BAP $216.87
- FMS $26.28
- Resistance Level
- BAP $240.00
- FMS $27.33
- Average True Range (ATR)
- BAP 5.06
- FMS 0.35
- MACD
- BAP 0.94
- FMS -0.07
- Stochastic Oscillator
- BAP 81.86
- FMS 15.29
About BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.